@FiercePharma: Genzyme shareholder sues to stop Sanofi acquisition. Article | Follow @FiercePharma
> Roche has added to its portfolio of diagnostics products by acquiring U.S.-based BioImagene, which specializes in tissue-based cancer diagnostics, for $100 million. Article
> Africa's biggest generic drugmaker Aspen Pharmacare said full-year headline earnings per share likely rose by 25 percent boosted by its South African operations. Report
> Irish drug maker Warner Chilcott has completed a loan and a debt offering necessary to pay a special dividend of $8.50 per share that it announced last month. Story
> Sun Pharmaceutical Industries said it is planning to enter the Japanese generics market, with drugs aimed at treating chronic diseases. Story
> Novartis is seeking to use Swiss merger law to push through its buy of a minority stake in U.S. eyecare firm Alcon (ACL.N), which would give it full control of the group. Item
> British drugmaker AstraZeneca spent $740,000 in the second quarter lobbying the U.S. federal government, according to a recent disclosure form. News
> GlaxoSmithKline spent just over $1.2 million lobbying federal officials on patent laws and other issues during the second quarter, according to a recent disclosure form. Article
@FierceBiotech: Which biotechs are the least efficient? News | Follow @FierceBiotech
Biotech News
> Taligen gets $10M cash injection for rare disease platform. Item
> Hep E vaccine aces large late-stage study in China. Article
> U.S. biotech faces fierce international competition. Story
> EpiCept shares hammered after FDA rejects app, demands new trial. News
> Archimedes starts recruiting for new U.S. headquarters. Report
Biotech IT News
> Roche writes social media rules for employees. Item
> Top 10 list rejects cloud for clinical data. News
> UK study supports dose-response modeling. Story
> Google-like code aids drug development. Report
> NIH funds software-based brain plasticity trials. Article
> Cloud to host Saffron predictive analytics tool. News
And Finally... What happens to attention, memory and learning when we step away from our devices and rest our brains? Report